Eisai initiatives 42.5B yen world income for LEQEMBI in FY2024 amid pathway enlargement

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages BioAge Labs, Inc. Traders to Safe Counsel Earlier than Necessary Deadline in Securities Class Motion – BIOA

Why Microchip would somewhat borrow cash to pay its excessive dividend than lower it

The FTSE 100 index hits new highs! However will Authorized & Basic shares outperform it in 2025?